Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Distribution of pathogens and predictive values of biomarkers of inflammatory response at ICU admission on outcomes of critically ill COVID-19 patients (CROSBI ID 316617)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Ćurčić, Maja ; Tarle, Marko ; Almahariq, Hani ; Hleb, Sonja ; Havaš, Juraj ; Pražetina, Marko ; Lasić, Hrvoje ; Dolenc, Emil ; Kukoč, Andrea ; Mihelčić, Antonija et al. Distribution of pathogens and predictive values of biomarkers of inflammatory response at ICU admission on outcomes of critically ill COVID-19 patients // Diagnostics, 12 (2022), 9; 2069, 17. doi: 10.3390/diagnostics12092069

Podaci o odgovornosti

Ćurčić, Maja ; Tarle, Marko ; Almahariq, Hani ; Hleb, Sonja ; Havaš, Juraj ; Pražetina, Marko ; Lasić, Hrvoje ; Dolenc, Emil ; Kukoč, Andrea ; Mihelčić, Antonija ; Miko, Ivan ; Romić, Andrea ; Tipura, Danijela ; Drmić, Željka ; Čučković, Marcela ; Blagaj, Vanja ; Lukšić, Ivica ; Peršec, Jasminka ; Šribar, Andrej

engleski

Distribution of pathogens and predictive values of biomarkers of inflammatory response at ICU admission on outcomes of critically ill COVID-19 patients

Background: Superinfections contribute to mortality and length of stay in critically ill COVID-19 patients. The aim of this study was to determine the incidence and pathogen distribution of bacterial and fungal superinfections of the lower respiratory tract (LRTI), urinary tract (UTI) and bloodstream (BSI) and to determine the predictive value of biomarkers of inflammatory response on their ICU survival rates. Methods: A retrospective observational study that included critically ill COVID-19 patients treated during an 11-month period in a Croatian national COVID-19 hospital was performed. Clinical and diagnostic data were analyzed according to the origin of superinfection, and multivariate regression analysis was performed to determine the predictive values of biomarkers of inflammation on their survival rates. Results: 55.3% critically ill COVID-19 patients developed bacterial or fungal superinfections, and LRTI were most common, followed by BSI and UTI. Multidrug- resistant pathogens were the most common causes of LRTI and BSI, while Enterococcus faecalis was the most common pathogen causing UTI. Serum ferritin and neutrophil count were associated with decreased chances of survival in patients with LRTI, and patients with multidrug-resistant isolates had significantly higher mortality rates, coupled with longer ICU stays. Conclusion: The incidence of superinfections in critically ill COVID-19 patients was 55.3%, and multidrug-resistant pathogens were dominant. Elevated ferritin levels and neutrophilia at ICU admission were associated with increased ICU mortality in patients with positive LRTI.

COVID-19 ; intensive care medicine ; superinfection ; survival analysis

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

12 (9)

2022.

2069

17

objavljeno

2075-4418

10.3390/diagnostics12092069

Povezanost rada

Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje), Kliničke medicinske znanosti

Poveznice
Indeksiranost